SRCAP靶向药基因

基因名称:SRCAP  (Snf2 related CREBBP activator protein)

别名: EAF1,FLHS,SWR1,DOMO1
基因ID:10847
Chromosome(GRCh37) :16 Start: 30709571 End: 30751450 Strand:
信号通路:
靶向药:
化疗药:

简介:该基因编码多蛋白染色质重塑SRCAP复合物的核心催化成分编码的蛋白质是一种atp酶,是将组蛋白变体h2a.z并入核小体所必需的。它在notch介导、creb介导和类固醇受体介导的转录中起转录激活作用。这种基因的突变会导致浮港综合症,一种罕见的疾病,其特征是身材矮小、语言缺陷和面部畸形[ RefSeq,FEB 2012 ]提供This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]
SRCAP突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务